Financed over $38 million in SR&ED claims (and climbing)
Innovative funding for Innovators
Your Partner in SR&ED Financing
Our Story
How We Became Leaders in
SR&ED Tax Credit Financing
Easly is wholly owned and privately held by an award-winning U.S. company. Since 2019, we have financed over $42 million in SR&ED claims that have fueled innovation in Canada. We focus exclusively on SR&ED tax credit financing, allowing us to align our products with the government’s tax incentive program’s details. This customized approach mitigates our risks and allows us to offer more affordable capital to our customers. Even more importantly, our non-dilutive financing means you can gain advanced R&D funding while retaining 100% of your company’s equity.
Powering Innovation
Across Canada
The Benefits of Working
with Easly
Our customers come first
We are proud to help innovative businesses of all sizes access R&D funding to propel their companies, industries and country forward. We’re committed to providing a painless and professional CaaS experience and value transparency and consistency in our process and operations. Our customer-first mindset has propelled us to the top of our industry. Learn more about our customers.
Non-dilutive financing
We want you to hold onto more of your company’s equity and will never ask you to give away any portion of ownership in exchange for advanced funding.
Instead, we want you to invest in what is profitable for your business, and beneficial to innovation in Canada. This is the driving force behind our commitment to R&D funding.
Receive your first advance in as little as 72 hours
We have cut the red tape when it comes to SR&ED tax credit financing, making it possible for you to access your first advance in as little as 72 hours. Receive your funding with efficiency so you can focus on pressing forward with R&D and improving your company’s market position.
Without advanced funding, it could take up to 18 months from when you incurred SR&ED costs to when you receive the SR&ED tax incentive refund. For many businesses, this delay significantly impacts their progress and compromises market opportunities. Instead, take advantage of our non-dilutive financing to scale your business without delays or unreasonable financial constraints.
Move Canadian innovation forward
With reliable, advanced funding, you’re empowered to build long-term value for your innovative company – year after year. Steady cash flow allows you to fine-tune R&D on demand. Fewer stalled or halted projects, and no more wasting valuable time while your competitors inch closer to a breakthrough.
Our SR&ED tax credit financing services promote discoveries in science and technology, which begin with your R&D teams. We’ll partner with you as you make the next big discovery, which can propel your company to the forefront of your industry.
Our Reputation and Performance Speak for Themselves
Working capital is the lifeline of any business, promoting growth and opening opportunities that fuel innovation. That is why trust is essential when it comes to R&D funding.
Easly’s reputation centers on consistent performance – getting our customers capital they can put to work today.
To date, we have:
.png)
Facilitated individual claims ranging from $50,000 to over $2,000,000.
Our achievements and reputation give our customers peace of mind, so they can focus on leading their companies through the next wave of growth.
"The financing that Easly offers is very cost-effective from a purely opportunity cost of capital point of view. It's a very low-cost way for a small tech company to grow and sustain operations."
Hassaan Ahmad · CFO, WTFast
"I've spoken to many companies that promised quick turnarounds for approvals & funding. All of them either missed that target by weeks or came back with a ridiculous offer we could never accept. Easly was true to their word and responded quickly with a competitive offer that met our needs. The whole process was refreshing and surprisingly streamlined!"
Jaed Khan · CEO, Foodmaestro
"Easly has been very good to us. They give us financial options at a rate and frequency that small technology companies absolutely need. I appreciate the online process a lot - being able to just upload financial documents is really, really convenient. We now use Easly quarterly draws as part of our financial model. It's not about survival; it's about strategy."
Dom Kwong · CTO & Founder, Damon Motorcycles
"Easly is a customer-focused organization. The process was efficient and focused on the parts that matter, as opposed to the red tape, and delivered above and beyond our expectations. They proved to us that they are the best source of R&D financing on the market."
Sean McCann · President, MMIST Inc.
"Easly played a critical role in our ability to keep the company's finances healthy. Their funds helped bridge us from survival to product-market fit, and it's difficult to envision us having the success we're seeing today without Easly. They're definitely our first call if we choose to go down the R&D financing path again."
Martin Kratky-Katz · CEO, Blockthrough
"We initially went with Easly because they had the most competitive rates by far. Even more compelling though ended up being the transparent and streamlined process that just made sense. The communication was smooth and I always felt certain about the outcome. I’d recommend them to anyone planning to file for an SR&ED refund."
Tristan Lehari · CEO, TritonWear
SR&ED News
How Canadian Tech Companies Can Utilize NRC IRAP Grants & SR&EDTechnology companies play an essential role in Canada’s economy, with the tech sector representing nearly 5% of its total. The…
Read More »- Entos Pharmaceuticals COVID-19 Vaccine Prepares for Phase 1 Clinical Trials with Help from Canada’s NRC IRAP Program
Canada’s first COVID-19 case occurred in Toronto on January 25, 2020. Since then, millions of cases have been reported around…
Read More » - Did Your SR&ED Claim Get Denied? 7 Steps You Should Take.
If your company engages in research and development (R&D), it likely participates in the Canada Revenue Agency’s Scientific Research &…
Read More »
Footer CTA
